Share:
Commentary

Solidarity and Voluntarism Amid the COVID-19 Pandemic: Skin Cancer Screening for Blood Donors Supporting volunteer blood donors through skin cancer screening

Supporting volunteer blood donors through skin cancer screening

Author Affiliation(s)

Abstract

Many of the volunteer activities required to raise public awareness on skin cancer screening and prevention are supported by dermatological societies and volunteer dermatologists, and are framed by substantial voluntary groups, often not sufficiently credited for their contribution, including blood donors and Red Cross Samaritans. We herein propose that amid the ongoing pandemic, skin cancer screening and blood donations must not be disrupted with attention paid to patient safety foremost. Although efforts over the last decade have led to a significant reduction in skin cancer, ongoing activities have been suspended and, in many cases, disrupted since the coronavirus disease 2019 (COVID-19) spread has created a Public Health Emergency of International Concern. International Health systems are burdened, and patients ignore symptoms and evade specialist visits due to contamination fear of coronavirus, resulting in a 68.61% reduction in skin cancer diagnoses. However, the COVID-19 pandemic has also major implications for blood transfusion. Currently, there are uncertain patterns of demand, and transfusion institutions need to plan for reductions in donations and loss of crucial staff because of sickness and public health restrictions. Supporting volunteer blood donors through voluntary skin cancer screening could be an excellent initiative, bringing people together, giving us the opportunity to abandon the illusion of power and admit our weakness to the ongoing pandemic. Most of us have not worked through pandemics before but it is time to embrace humanity and solidarity via volunteering, with no profit aims but with social goals of equal skin cancer screening opportunities of vitally important volunteer blood donors, encouraging blood donation. In light of a change in dermatology practice, investing in prevention strategies in public health and social protection is the mark of responsible policy action. 

Keywords : skin cancer screening, volunteer blood donors, teledermatology, international red cross, public health, solidarity

References

1. Andrew TW, Alrawi M, Lovat P. Reduction in skin cancer diagnoses in the UK during the COVID-19 pandemic. Clin Exp Dermatol. 2020;46(1):145-146. DOI: 10.1111/ced.14411. PMID: 32754962. 2. Sen-Crowe B, McKenney K, McKenney M, Elkbuli A. Challenges associated with blood banks and blood donations during the COVID-19 pandemic. Am J Emerg Med. 2020;20: 30546-5. DOI: 10.1016/j.cll.2020.08.013. PMID: 32674923. 3. International Federation of the Red Cross (IFRC) Voluntary blood donation. Accessed November 28, 2020. https://media.ifrc.org/ifrc/what-we-do/health/voluntary-blood-donation/ 4. American Academy of Dermatology Association. Free skin cancer screenings. Accessed November 28, 2020. https://www.aad.org/public/public-health/skin-cancer-screenings 5. Malhi IS, Yiu ZZN. Algorithm-based smartphone apps to assess risk of skin cancer in adults: critical appraisal of a systematic review. Br J Dermatol. 2020 Aug 31. DOI: 10.1111/bjd.19502. PMID: 32866990. 6. Tognetti L, Cevenini G, Moscarella E, et al. Validation of an integrated dermoscopic scoring method in a European teledermoscopy web platform: the iDScore project for early detection of melanoma. J Eur Acad Dermatol Venereol. 2020;34(3):640-647. DOI: 10.1111/jdv.15923. PMID: 31465600. 7. Hadeler EK, Beer J Nouri K. Teledermatology: improving access or widening healthcare disparities? 2020;19(12):1248. DOI: 10.36849/JDD.2020.5693. PMID: 33346507. 8. Massone C, Maak D, Hofmann-Wellenhof R, Soyer HP, Frühauf J. Teledermatology for skin cancer prevention: an experience on 690 Austrian patients. J Eur Acad Dermatol Venereol. 2014;28(8):1103-1108. DOI: 10.1111/jdv.12351. PMID: 24372877. 9. Kazi R, Evankovich MR, Liu R, et al. Utilization of asynchronous and synchronous teledermatology in a large health care system during the COVID-19 pandemic. Telemed J E Health. 2020 Oct 19. DOI: 10.1089/tmj.2020.0299. PMID: 33074786.

Send mail to Author


Send Cancel